It’s always an event when we spend time together

Alternative Methods to Animal Testing

This presentation will explore the transformative potential of organ-chip technology in advancing drug development and reducing animal testing. This session will highlight the principles of organ-on-chip (OOC) technology, showcasing liver, intestine, and lung models to demonstrate insights into drug responses and pathophysiological mechanisms.
Key highlights:

• Liver-Chips: Performance characterization of the Liver-Chip within the context of predicting drug-induced liver injury.
• Colon Intestine-Chips: Gain an unparalleled window into IBD with the colon- and inflammation-specific model of human immune cell recruitment.
• Immuno-Oncology: Model inflammation-specific CAR T-cell recruitment and antigen-specific cancer cell killing in a Non-Small Cell Lung Cancer (NSCLC) model

Join us to discover how OOC technology can revolutionize drug development and pave the way for more ethical, efficient, and human-relevant biomedical research.

Christine Lansche, PhD, Emulate